Skip to main content

Frost Phillip MD Et Al's Form 4 filing

Opko Health, Inc. (OPK) ยท filed Nov 13, 2023

Accession no.
0001209191-23-054919
Filed
Nov 13, 2023, 8:23 AM ET
Trade date
Nov 9-10, 2023
Filing delay
4 days
Rule 10b5-1 plan
Not checked

This filing lists 22 non-derivative transactions. Open-market purchases total $1.27M. It was filed 4 days after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Frost Phillip MD Et AlCIK 0000898860Director, Officer (CEO & Chairman), 10% Owner
Frost Gamma Investments TrustCIK 000138089610% Owner

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Nov 9, 2023Common StockPPurchaseAcquired+10,101$1.27+$12,777.77200,966,795Indirect
Nov 9, 2023Common StockPPurchaseAcquired+56,199$1.27+$71,372.73201,022,994Indirect
Nov 9, 2023Common StockPPurchaseAcquired+618$1.27+$786.41201,023,612Indirect
Nov 9, 2023Common StockPPurchaseAcquired+93,319$1.28+$118,981.73201,116,931Indirect
Nov 9, 2023Common StockPPurchaseAcquired+149,763$1.28+$191,696.64201,266,694Indirect
Nov 9, 2023Common StockPPurchaseAcquired+12,273$1.29+$15,770.81201,278,967Indirect
Nov 9, 2023Common StockPPurchaseAcquired+62,480$1.29+$80,599.2201,341,447Indirect
Nov 9, 2023Common StockPPurchaseAcquired+67,147$1.30+$86,955.37201,408,594Indirect
Nov 9, 2023Common StockPPurchaseAcquired+48,100$1.30+$62,530201,456,694Indirect
Nov 10, 2023Common StockPPurchaseAcquired+1,900$1.22+$2,322.75201,458,594Indirect
Nov 10, 2023Common StockPPurchaseAcquired+87,776$1.23+$107,525.6201,546,370Indirect
Nov 10, 2023Common StockPPurchaseAcquired+50,000$1.24+$61,750201,596,370Indirect
Nov 10, 2023Common StockPPurchaseAcquired+5,324$1.24+$6,601.76201,601,694Indirect
Nov 10, 2023Common StockPPurchaseAcquired+19,072$1.25+$23,744.64201,620,766Indirect
Nov 10, 2023Common StockPPurchaseAcquired+49,481$1.25+$61,851.25201,670,247Indirect
Nov 10, 2023Common StockPPurchaseAcquired+500$1.25+$626.25201,670,747Indirect
Nov 10, 2023Common StockPPurchaseAcquired+39,202$1.26+$49,198.51201,709,949Indirect
Nov 10, 2023Common StockPPurchaseAcquired+138,871$1.26+$174,977.46201,848,820Indirect
Nov 10, 2023Common StockPPurchaseAcquired+400$1.26+$505201,849,220Indirect
Nov 10, 2023Common StockPPurchaseAcquired+24,300$1.27+$30,739.5201,873,520Indirect
Nov 10, 2023Common StockPPurchaseAcquired+4,500$1.27+$5,703.75201,878,020Indirect
Nov 10, 2023Common StockPPurchaseAcquired+78,674$1.27+$99,915.98201,956,694Indirect

Footnotes and remarks

Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.

No transaction price on this filing refers to a footnote.

Read the full filing on SEC EDGAR (opens in a new tab)